Save time and get answers to complex questions with AI chat
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Xenazine current manufacturer 2025?Allergan's patent for latisse expired?Mebendazole for kids price?Somatuline depot patent expiry date?
See the DrugPatentWatch profile for Ivermectin
Ivermectin isn’t controlled by a single company. The supply chain involves multiple players and varies by region. In broad terms: - Innovator and donation program: Merck & Co. developed ivermectin (Stromectol) for human use and runs the Mectizan Donation Program for river blindness and other parasitic diseases. They are a cornerstone reference for the drug, but they don’t supply most generic markets directly. - API manufacturers: Many generic API producers manufacture ivermectin API (the raw drug). These are largely in India and other parts of Asia, with some activity in Europe and the Americas. The exact list of API suppliers changes over time and by regulatory approvals. - Finished-dose manufacturers: Numerous contract manufacturers and pharmaceutical companies formulate the API into tablets, suspensions, and other dosage forms for human and veterinary use. - Distributors and wholesalers: After production, products move through global and regional distribution networks to pharmacies, clinics, and hospitals. If you’d like, I can tailor the information to your needs. For example: - Want region-specific API or finished-dose manufacturers (e.g., India, US, Europe)? - Do you want a current, sourced list of known API producers and/or finished-dose manufacturers? - Are you looking for regulatory statuses (GMP certificates, WHO prequalification, FDA/EMEA approvals)? Tell me your region and whether you want API suppliers, finished-dose manufacturers, or distributors, and I’ll pull a current, more detailed overview.
Other Questions About Ivermectin :